XERS - Xeris Pharmaceuticals Inc. (XERS) CEO Paul Edick on Q2 2020 Results - Earnings Call Transcript
Xeris Pharmaceuticals, Inc. (XERS)
Q2 2020 Earnings Conference Call
August 10, 2020 08:30 a.m. ET
Company Representatives
Paul Edick - Chairman, Chief Executive Officer
Barry Deutsch - Chief Financial Officer
Allison Wey - Senior Vice President of Investor Relations & Corporate Communication
Conference Call Participants
Zach Sachar - Piper Sandler
Ed Chung - Jefferies
Daniel Busby - RBC Capital Markets
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Xeris Pharmaceuticals Second Quarter Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speakers’